Affinity Capital Advisors, LLC Eli Lilly & CO Transaction History

Affinity Capital Advisors, LLC

$470 Million
Q2 2024

A detailed history of Affinity Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Affinity Capital Advisors, LLC holds 5,801 shares of LLY stock, worth $5.24 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

5,801

Previous 5,801 -0.0%

Holding current value

$5.24 Million

Previous $4.51 Million 16.4%

% of portfolio

1.12%

Previous 1.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $136,798 - $183,016	-231 Reduced 3.83%	5,801 $4.51 Million
Q4 2023 Jan 11, 2024	SELL	$525.19 - $619.13 $58,821 - $69,342	-112 Reduced 1.82%	6,032 $3.52 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $12,171 - $16,780	28 Added 0.46%	6,144 $3.3 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $20,342 - $27,200	58 Added 0.96%	6,116 $2.87 Million
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $1,607 - $1,873	5 Added 0.08%	6,058 $0
Q3 2022 Oct 12, 2022	BUY	$296.48 - $337.87 $138,752 - $158,123	468 Added 8.38%	6,053 $1.96 Million
Q2 2022 Jul 11, 2022	BUY	$278.73 - $327.27 $27,873 - $32,727	100 Added 1.82%	5,585 $1.81 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $17,313 - $21,486	-77 Reduced 1.38%	5,485 $1.52 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 1.77%	5,562 $1.04 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $73,110 - $84,565	-500 Reduced 8.11%	5,662 $838,000
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $81,851 - $98,508	-600 Reduced 8.87%	6,162 $1.01 Million
Q1 2020 Apr 23, 2020	SELL	$119.05 - $147.35 $23,810 - $29,470	-200 Reduced 2.87%	6,762 $1.06 Million
Q4 2019 Apr 23, 2020	BUY	$106.92 - $132.43 $744,377 - $921,977	6,962 New	6,962 $915,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Capital Advisors, LLC with notifications on news.

Account

Affinity Capital Advisors, LLC Eli Lilly & CO Transaction History